Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair

NCT00927758 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT00927758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00927758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair
Lead sponsor
Sandoz
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
December 31, 2009
Enrollment
105 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

asthma